Prosecution Insights
Last updated: November 04, 2026

Gorgio International Holding LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 1 of 1 (100%) have an AI response strategy ready

Analysis

Gorgio International Holding LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner within 1 distinct art unit. The concentration of the portfolio into a single point of contact indicates a narrow prosecution focus for the current pending matters. This structure allows for a highly targeted strategy that addresses the specific requirements of 1 technical group.

BOECKELMAN, JACOB A is the busiest examiner for the company with 1 pending office action. This examiner accounts for the entirety of the pending workload. Practitioners should note that the prosecution strategy for this portfolio is currently tied to the specific tendencies of this 1 examiner and 1 art unit. Since there is only 1 pending action, the company does not currently face the challenge of coordinating across multiple examiner preferences or art unit policies.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOECKELMAN, JACOB A 1 34.6% +46.8%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18860664 Malt Supplement Containing Oleocanthal, with Anti-inflammatory, Antioxidant, and Anti-cancer Properties BOECKELMAN, JACOB A —

Top Art Units

Art UnitApps
1655 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18860664 Malt Supplement Containing Oleocanthal, with Anti-inflammatory, Antioxidant, and Anti-cancer Properties BOECKELMAN, JACOB A 1655 §112 Non-Final OA — AI Ready Oct 27, 2024

Managing Gorgio International Holding LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Gorgio International Holding LLC have?

Gorgio International Holding LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Gorgio International Holding LLC applications?

Jacob A Boeckelman has the most, with 1 of Gorgio International Holding LLC's pending office actions.

What technology area are Gorgio International Holding LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month